Blue light, a high energy component of visible light spectrum (380-500 nm), has been reported to have various biological impacts on skin. While it has long been associated with phototoxic effects, recent studies have demonstrated its therapeutic poten...
Blue light, a high energy component of visible light spectrum (380-500 nm), has been reported to have various biological impacts on skin. While it has long been associated with phototoxic effects, recent studies have demonstrated its therapeutic potential in treating several skin disorders. However, our understanding of the biological effects of blue light remains limited and largely based on phenotypic observations, raising concerns regarding its long-term safety and highlighting the need to delineate the underlying molecular mechanisms. This study aims to elucidate the molecular mechanisms of blue light-induced skin responses and to identify target molecules that may enhance the safety and efficacy of blue light therapy.
This study explored the effects of blue light on hyperpigmentation, anti-cancer responses and circadian rhythm regulation across various skin cell types. A key focus was the role of TRPV1, a non-selective cation channel expressed in skin cells, in mediating stress responses triggered by disruptions in cellular homeostasis, particularly fluctuations in intracellular calcium levels.
Notably, TRPV1 was identified as a downstream effector of OPN3. Blue light activated TRPV1 and upregulated its expressions via OPN3, inducing a calcium influx. Elevated intracellular calcium levels not only stimulated melanogenesis but also inhibited melanosome degradation, contributing to pigment accumulation. Furthermore, blue light activated TRPV1 localized on ER membrane, eliciting ER stress and triggering UPR. In melanoma cells, excessive ER stress attenuated IRE1α signaling, disrupted Ca2+ homeostasis and ultimately exerted anti-tumor effects. In keratinocytes, blue light-induced ER stress modulated circadian rhythm via ATF6 upregulation, potentially accelerating skin aging.
Collectively, these findings are expected to provide comprehensive insights into dermatologic responses to blue light and support the development of safter, more targeted and mechanism-based approaches in blue light therapy.